IGFBP3 and type 2 diabetes mellitus: This study suggests that a combined model incorporating serum IGF-1, IGF-1/IGFBP-3 molar ratio, and IGFBP-3 may offer a more robust predictive value for TNs in patients with T2DM compared to using individual biomarkers.